Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nortriptyline in Nonerosive Reflux Disease (NORGERD)
NCT01065649Phase 3Completed
- Sponsor
- Universidade de Passo Fundo
- Start
- Jan 2010
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nortriptyline in non-erosive reflux disease (NERD), sponsored by Universidade de Passo Fundo. Started Jan 2010; status: completed.
02
Drugs
nortriptyline
03
Conditions
non-erosive reflux disease (NERD)
Beyond the preview
Go deeper on NCT01065649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01065649.